Diabetic nephropathy as a cause of end-stage renal disease in Egypt: A six-year study

Eastern Mediterranean Health Journal

Volumn 10, Issue 4-5, 2004, Pages 620-626

  Afifi, A ^a   El Setouhy, M ^a   El Sharkawy, M ^a   Ali, M ^a   Ahmed, H ^a   El Menshawy, O ^b   Masoud, W ^c  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b MINIA UNIVERSITY   (Egypt)

^c Ahmed Maher's Teaching Hospital   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EGYPT; EPIDEMIOLOGICAL DATA; HUMAN; KIDNEY FAILURE; MORTALITY; OBSTRUCTIVE UROPATHY; PREVALENCE; REFLUX NEPHROPATHY; RENOVASCULAR HYPERTENSION; SAMPLE SIZE; SCHISTOSOMIASIS;

EID: 28444489632     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2004.10.4-5.620     Document Type: Article

References (26)

1. Afifi A. Sixth annual report of the Egyptian Society of Nephrology. Paper presented at the 22nd Congress of the Egyptian Society of Nephrology, 4-8 February 2003, Sharm El Sheikh, Egypt.
2. Ritz E et al. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. American journal of kidney disease, 1999, 34(5): 795-808.
3. Earle KK et al. Variation in the progression of diabetic nephropathy according to racial origin. Nephrology, dialysis, transplantation, 2001, 16(2):286-290.
4. Lee G. End-stage renal disease in the Asian-Pacific region. Seminars in nephrology, 2003, 23(1):107-14
5. US Renal Data System. USRDS 2002 annual data report. Bethesda, Maryland, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002.
6. Jager K, Van Dijk P. 2002 ERA-EDTA registry annual report, XXXIX ERA-EDTA congress. Copenhagen, Denmark, European Renal Association, 2002.
7. Hollenberg NK. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. Current hypertension reports, 2001, 3(3):177.
8. Halimi S et al. Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas French territories. A second national survey six years apart. (UREMIDIAB 2 study). Diabetes and metabolism, 1999, 25(6):507-12.
9. Frei U, Schober-Halstenberg HJ. Annual report of the German renal registry 1998. QuaSi-Niere task group for quality assurance in renal replacement therapy. Nephrology dialysis, transplantation, 1999, 14(5):1085-90.
10. Bergrem H, Leivestad T. Diabetic nephropathy and end-stage renal failure: the Norwegian story. Advances in renal replacement therapy, 2001, 8(1):4-12.
11. El-Sharkawi M. Changing pattern of etiology of chronic renal failure among dialysis patients [thesis]. Cairo, Ain Shams University, 1996.
12. Ahmed T. Clinical and laboratory features of patients with chronic renal failure at the start of dialysis [thesis]. Cairo, Ain Shams University, 1991.
13. Djukanovic L et al. Epidemiology of end-stage renal disease and current status of hemodialysis in Yugoslavia. International journal of artificial organs, 2002, 25(9):852-9.
14. Rutkowski B et al. Evolution of renal replacement therapy in Central and Eastern Europe 7 years after political and economical liberation. Nephrology, dialysis, transplantation, 1998, 13(4):860-4.
15. Rutkowski B et al. Renal replacement therapy in an era of socioeconomic changes - report from the Polish Registry Nephrology, dialysis, transplantation, 1997, 12(6):1105-8.
16. Mazzuchi N et al. Latin American registry of dialysis and renal transplantation: 1993 Annual dialysis data report. Nephrology, dialysis, transplantation, 1997, 12(12):2521-7.
17. Li L. End-stage renal disease in China. Kidney international, 1996, 49(1):287-301.
18. Yang WC et al. The impact of diabetes on economic costs in dialysis patients: experiences in Taiwan. Diabetes research and clinical practice, 2001, 54(suppl. 1):S47-54.
19. Al-Khader AA. Impact of diabetes in renal diseases in Saudi Arabia. Nephrology, dialysis, transplantation, 2001, 16(11):2132-5.
20. Ben Abdallah. Report of dialysis registry in Tunisia. Paper presented at the 21st Congress of the Egyptian Society of Nephrology, 15-20 February 2002, Cairo, Egypt.
21. El-Reshaid K et al. End-stage renal disease and renal replacement therapy in Kuwait-epidemiological profile over the past 4 1/2 years. Nephrology, dialysis, transplantation, 1994, 9(5):532-8.
22. Arab M. Diabetes mellitus in Egypt. World health statistics quarterly, 1992, 45(4): 334-7.
23. Harman WH et al. Diabetes mellitus in Egypt: risk factors and prevalence. Diabetic medicine, 1995, 12(12):1126-31.
24. Ibrahim T. Etiology of chronic renal failure among a sample of Egyptian population [thesis]. Cairo, Ain Shams University, 1998.
25. Afifi A, Karim MA. Renal replacement therapy in Egypt: first annual report of the Egyptian Society of Nephrology, 1996. Eastern Mediterranean health journal, 1999, 5(5):1023-9.
26. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes care, 1998, 21(9): 1414-31.